Prevena Therapy for Spine Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of the Prevena Vacuum-Assisted Closure device in healing after spine surgery. The device is applied to the incision area to potentially accelerate recovery and reduce complications. Participants who recently underwent spine surgery and required a plastic surgeon for closure may be eligible. Some participants will use the Prevena device, while others will serve as a comparison group based on past surgeries without it. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, allowing researchers to understand its benefits for a broader range of patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What is the safety track record for Prevena Spine?
Research has shown that Prevena Therapy is generally safe for use in surgeries. Studies have found that this therapy can help reduce infections in surgical wounds. Although specific data for spine surgery is not yet available, it has been used successfully in other types of surgeries.
Safety information from other surgeries suggests that Prevena is well-tolerated. A study that combined results from multiple studies confirmed its safety and effectiveness. This indicates that, even though it is still under study for spine surgery, it has been used safely in similar situations.
Overall, Prevena Therapy has a history of safety in surgical settings, but further research will help confirm its safety specifically for spine surgery.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about Prevena Therapy for spine surgery because it offers a unique approach to post-operative care. Unlike traditional wound care methods that rely on standard dressings, Prevena uses negative pressure wound therapy (NPWT) to help protect the incision site and promote healing. This technique can potentially reduce the risk of infection and complications by actively managing the wound environment, which is a significant advantage over conventional options. By targeting the incision area directly and maintaining optimal conditions for healing, Prevena might enhance recovery outcomes for patients undergoing spine surgery.
What evidence suggests that the Prevena device is effective for spine surgery?
Research shows that Prevena Therapy uses a gentle vacuum to aid wound healing after surgery. This method creates slight suction, reducing swelling and accelerating healing. Although few studies have focused on its use in spine surgery, similar methods have shown promise in other surgeries. In this trial, one group of participants will receive Prevena Therapy after spine surgery to evaluate its effectiveness for these patients. The therapy is already approved for other conditions, indicating its effectiveness in wound healing. However, more research is needed to confirm its efficacy specifically for spine surgery patients.14567
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are having spine surgery and need a plastic surgeon to close the wound. They must have a risk score of 80 or above, indicating they're at higher risk for complications. Pregnant individuals, those with low-risk scores, or with conditions that could affect study results or compliance can't participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo spine surgery and receive either Prevena or conventional wound dressing
Follow-up
Participants are monitored for surgical site infections, wound dehiscence, seroma, skin necrosis, and readmission
What Are the Treatments Tested in This Trial?
Interventions
- Prevena Spine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
3M
Industry Sponsor
Dr. John Banovetz
3M
Chief Medical Officer since 2017
PhD in Inorganic Chemistry from Stanford University, Bachelor's degree in Chemistry from Hamline University
William 'Bill' Brown
3M
Chief Executive Officer
Bachelor's and Master's degrees in Mechanical Engineering from Villanova University, MBA from The Wharton School, University of Pennsylvania